Literature DB >> 16754517

Airway hyperresponsiveness as a determinant of the early asthmatic response to inhaled allergen.

D W Cockcroft1, B E Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16754517     DOI： 10.1080/02770900600566348

Source DB:  PubMed          Journal:  J Asthma        ISSN： 0277-0903            Impact factor:   2.515


× No keyword cloud information.
  8 in total

1.  High IFN-γ and low SLPI mark severe asthma in mice and humans.

Authors:  Mahesh Raundhal; Christina Morse; Anupriya Khare; Timothy B Oriss; Jadranka Milosevic; John Trudeau; Rachael Huff; Joseph Pilewski; Fernando Holguin; Jay Kolls; Sally Wenzel; Prabir Ray; Anuradha Ray
Journal:  J Clin Invest       Date:  2015-06-29       Impact factor: 14.808

Review 2.  Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.

Authors:  Christopher J Cates; Marta Oleszczuk; Elizabeth Stovold; L Susan Wieland
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 3.  Current concepts of severe asthma.

Authors:  Anuradha Ray; Mahesh Raundhal; Timothy B Oriss; Prabir Ray; Sally E Wenzel
Journal:  J Clin Invest       Date:  2016-07-01       Impact factor: 14.808

4.  Regional variation and adherence to guidelines for drug treatment of asthma.

Authors:  Marianne Heibert Arnlind; Björn Wettermark; Mika Nokela; Paul Hjemdahl; Clas Rehnberg; Eva Wikström Jonsson
Journal:  Eur J Clin Pharmacol       Date:  2009-10-14       Impact factor: 2.953

Review 5.  Regular treatment with salmeterol for chronic asthma: serious adverse events.

Authors:  Christopher J Cates; Matthew J Cates
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

Review 6.  Regular treatment with formoterol for chronic asthma: serious adverse events.

Authors:  Christopher J Cates; Matthew J Cates
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 7.  Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.

Authors:  Christopher J Cates; L Susan Wieland; Marta Oleszczuk; Kayleigh M Kew
Journal:  Cochrane Database Syst Rev       Date:  2014-02-06

8.  Graphene oxide attenuates Th2-type immune responses, but augments airway remodeling and hyperresponsiveness in a murine model of asthma.

Authors:  Michael R Shurin; Naveena Yanamala; Elena R Kisin; Alexey V Tkach; Galina V Shurin; Ashley R Murray; Howard D Leonard; Jeffrey S Reynolds; Dmirtiy W Gutkin; Alexander Star; Bengt Fadeel; Kai Savolainen; Valerian E Kagan; Anna A Shvedova
Journal:  ACS Nano       Date:  2014-05-23       Impact factor: 15.881
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.